Education
About Us
Working with TipRanks
Follow Us
Torrent Pharmaceuticals Ltd (IN:TORNTPHARM)
:TORNTPHARM
Total Valuation
Torrent Pharmaceuticals Ltd has a market cap or net worth of ₹1.22T. The enterprise value is ―.
Market Cap₹1.22T
Enterprise Value―
Share Statistics
Torrent Pharmaceuticals Ltd has 338,445,430 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding338,445,430
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Torrent Pharmaceuticals Ltd’s return on equity (ROE) is 0.25 and return on invested capital (ROIC) is 34.69%.
Return on Equity (ROE)0.25
Return on Assets (ROA)0.13
Return on Invested Capital (ROIC)34.69%
Return on Capital Employed (ROCE)0.57
Revenue Per Employee7.33M
Profits Per Employee1.22M
Employee Count15,718
Asset Turnover0.77
Inventory Turnover1.09
Valuation Ratios
The current PE Ratio of Torrent Pharmaceuticals Ltd is 60.9. Torrent Pharmaceuticals Ltd’s PEG ratio is 3.66.
PE Ratio60.9
PS Ratio9.36
PB Ratio14.19
Price to Fair Value14.19
Price to FCF54.58
Price to Operating Cash Flow0.00
PEG Ratio3.66
Income Statement
In the last 12 months, Torrent Pharmaceuticals Ltd had revenue of 115.16B and earned 19.11B in profits. Earnings per share was 56.47.
Revenue115.16B
Gross Profit87.40B
Operating Income58.88B
Pretax Income26.73B
Net Income19.11B
EBITDA36.76B
Earnings Per Share (EPS)56.47
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Torrent Pharmaceuticals Ltd pays an annual dividend of ₹6, resulting in a dividend yield of 0.89%
Dividend Per Share₹6
Dividend Yield0.89%
Payout Ratio68.60%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.57
52-Week Price Change13.55%
50-Day Moving Average3.58K
200-Day Moving Average3.34K
Relative Strength Index (RSI)54.81
Average Volume (3m)6.02K
Important Dates
Torrent Pharmaceuticals Ltd upcoming earnings date is Jan 22, 2026, TBA (Confirmed).
Last Earnings DateOct 22, 2025
Next Earnings DateJan 22, 2026
Ex-Dividend DateJun 20, 2025
Financial Position
Torrent Pharmaceuticals Ltd as a current ratio of 1.19, with Debt / Equity ratio of 42.18%
Current Ratio1.19
Quick Ratio0.65
Debt to Market Cap0.03
Net Debt to EBITDA0.71
Interest Coverage Ratio23.37
Taxes
In the past 12 months, Torrent Pharmaceuticals Ltd has paid 7.62B in taxes.
Income Tax7.62B
Effective Tax Rate0.28
Enterprise Valuation
Torrent Pharmaceuticals Ltd EV to EBITDA ratio is 30.03, with an EV/FCF ratio of 55.91.
EV to Sales9.58
EV to EBITDA30.03
EV to Free Cash Flow55.91
EV to Operating Cash Flow42.70
Balance Sheet
Torrent Pharmaceuticals Ltd has ₹6.88B in cash and marketable securities with ₹0.00 in debt, giving a net cash position of ₹6.88B billion.
Cash & Marketable Securities₹6.88B
Total Debt₹0.00
Net Cash₹6.88B
Net Cash Per Share₹20.33
Tangible Book Value Per Share₹88.32
Margins
Gross margin is 69.36%, with operating margin of 51.13%, and net profit margin of 16.59%.
Gross Margin69.36%
Operating Margin51.13%
Pretax Margin23.21%
Net Profit Margin16.59%
EBITDA Margin31.92%
EBIT Margin25.41%
Analyst Forecast
The average price target for Torrent Pharmaceuticals Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast7.63%
EPS Growth Forecast15.39%